NovaBridge Biosciences (NBP) Other Accumulated Expenses (2022 - 2025)

NovaBridge Biosciences (NBP) has 4 years of Other Accumulated Expenses data on file, last reported at $9.2 million in Q4 2025.

• Quarterly Other Accumulated Expenses rose 8560.38% year-over-year to $9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.2 million (up 8560.38% YoY) and the FY2025 annual result came in at $9.2 million, up 8560.38% from the prior year.
• Other Accumulated Expenses rose to $9.2 million in Q4 2025 per NBP's latest filing, from $106000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $9.2 million in Q4 2025 and bottomed at $106000.0 in Q4 2024.
• The 4-year median for Other Accumulated Expenses is $7.0 million (2022), against an average of $5.8 million.
• The widest annual swing landed in 2024, when Other Accumulated Expenses sank 97.82%; it then surged 8560.38% in 2025.
• Tracing NBP's Other Accumulated Expenses over 4 years: stood at $9.1 million in 2022, then sank by 46.54% to $4.9 million in 2023, then slumped by 97.82% to $106000.0 in 2024, then surged by 8560.38% to $9.2 million in 2025.
• Per Business Quant, the three latest NBP Other Accumulated Expenses figures stand at $9.2 million (Q4 2025), $106000.0 (Q4 2024), and $4.9 million (Q4 2023).

Peer Comparison